Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
- The 25 day SEC-enforced quiet period for XENT will expire on August 17.
- On August 18 XENT's IPO underwriters can release analyses of the ear, nose, and throat drug device company, likely leading to at least a temporary rise in shares.
- Research has shown above-market returns of 2.3% in the 8 day (-5, +2) period, surrounding a company's IPO quiet period expiration.
- Given that XENT is already gaining ground in the market, the event could be an additional boost and create a new buying opportunity.
- Additional information here.
Disclosure: The author is long XENT.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
